CRTO 241220 40.00C (CRTO241220C40000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

CRTO241220C40000

Watchlist

2.55
+0.55+27.50%

15min DelayClose Nov 27 16:00 ET

2.55High2.25Low

Intraday

5D
Daily

News

Insider Sale: Chief Legal Officer of $CRTO (CRTO) Sells 2,885 Shares
Quiver QuantitativeNov 26 16:17 ET
Is Criteo S.A.'s (NASDAQ:CRTO) Stock Price Struggling As A Result Of Its Mixed Financials?
Simply Wall StNov 24 07:25 ET
European Equities Traded in the US as American Depositary Decline Slightly in Tuesday Trading
MT NewswiresNov 19 11:18 ET
Decoding 5 Analyst Evaluations For Criteo
BenzingaNov 19 09:01 ET
Benchmark Co. Maintains Criteo(CRTO.US) With Buy Rating, Maintains Target Price $51
Moomoo NewsNov 19 08:31 ET · Ratings
A Quick Look at Today's Ratings for Criteo(CRTO.US), With a Forecast Between $41 to $51
Moomoo NewsNov 19 08:00 ET · Ratings

Comments

Bigmoney Dreamer

Jul 23 00:45

$Criteo (CRTO.US)$ Support and Resistance Levels
Support Level@$39.83, established through clear consolidation after the last breakout.
Resistance Level@ 52-week High at $45, representing a significant psychological barrier for investors. These levels are instrumental in identifying potential entry and exit points for trades, highlighting areas of buyer and seller equilibrium.

Moomoo AI

Mar 17 07:58

Despite strong share performance, the market may not be judging the company on earnings growth due to decreased earnings per share. Revenue and earnings trends could have influenced share price. The gain surpassed the average annual return of 7% over five years, suggesting the company may be attracting new investors.

Optimism for Criteo (NASDAQ:CRTO) Has Grown This Past Week, Despite Five-year Decline in Earnings

Moomoo AI

Mar 1 17:41

Petrus Advisers views Criteo as an 'attractive investment opportunity' that could be strengthened by requested actions. Ocular Therapeutix's leadership changes are seen as a positive step towards becoming a leader in retina care. Starboard previously labeled Fortrea shares as 'undervalued' and an 'attractive investment opportunity'.

Criteo, Ocular Therapeutix, and More Stocks See Action From Activist Investors -- Barrons.com

Moomoo AI

Feb 28 13:53

The CEO & Director's recent share selling, even at below current price, may indicate insiders see the shares as fully valued. Despite significant insider ownership, the long-term outlook lacks positivity.

Don't Ignore The Insider Selling In Criteo

Moomoo AI

Feb 22 10:25

Petrus Advisers urges Criteo for a strategic review and an investor day to explain the Retail Media strategy and a new mid-term plan, believing the current stock fluctuation is not rewarding.

Criteo Gains as Activist Pushes for Strategic Review, Board Refresh